Vicarious Surgical (RBOT) Non Operating Investment Income (2021 - 2025)
Vicarious Surgical's (RBOT) quarterly Non Operating Investment Income came in at -$18000.0 in Q2 2025, down 80.0% year-on-year from -$90000.0 in Q2 2024, and up 43.75% on a QoQ basis from -$32000.0 in Q1 2025.
Vicarious Surgical (RBOT) Non Operating Investment Income (2021 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 4 years of Non Operating Investment Income data on file, last reported at -$18000.0 in Q2 2025.
- On a quarterly basis, Non Operating Investment Income fell 80.0% year-over-year to -$18000.0 in Q2 2025; TTM through Jun 2025 was $51000.0, a 35.44% decrease from a year earlier, with the FY2024 full-year figure at $40000.0, up 300.0% from the prior year.
- Non Operating Investment Income for Q2 2025 stood at -$18000.0, up from -$32000.0 in the prior quarter.
- Over the last five years, Non Operating Investment Income for RBOT reached as high as $175000.0 in Q3 2024 and fell as low as -$195000.0 in Q2 2023.
- Historically, Non Operating Investment Income has averaged $6187.0 across 4 years, with a median of -$1513.5 in 2021.
- On a YoY basis, Non Operating Investment Income climbed as much as 326.83% in 2024 and fell as far as 178.46% in 2024.
- Year by year, Non Operating Investment Income stood at $6973.0 in 2021, then jumped by 1319.76% to $99000.0 in 2023, then slumped by 174.75% to -$74000.0 in 2024, then soared by 75.68% to -$18000.0 in 2025.
- Per Business Quant data, the three most recent Non Operating Investment Income figures were -$18000.0 in Q2 2025, -$32000.0 in Q1 2025, and -$74000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -18,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -51,000.00 |
| Mar 31, 2024 | -51,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Jun 30, 2023 | -195,000.00 |
| Jun 30, 2023 | -195,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Mar 31, 2023 | 65,000.00 |